Barclays upgraded Newmed Energy (DKDRF) to Equal Weight from Underweight with a price target of ILS 14.20, up from ILS 11. Israeli companies navigated 2024 with “remarkable strength,” the analyst tells investors in a research note. Looking ahead, the firm sees most upside potential across banks, insurance and real estate. Inline with its relative rating approach Barclays adjusted ratings into 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.